UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|8/21/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and moreStat News|8/21/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and moreStat News|8/20/2026
LINDYsurvived 2 daysSTAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and moreStat News|8/19/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and moreStat News|8/18/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and moreStat News|8/17/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|8/14/2026